Intestinal barrier disorders and metabolic endotoxemia in obesity: Current knowledge

[1] World Health Organization. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. World Health Organization Obesity and overweight https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Search in Google Scholar

[2] Fasano A. Gut permeability, obesity, and metabolic disorders: Who is the chicken and who is the egg? Am J Clin Nutr. 2017; 105: 3–4. FasanoA Gut permeability, obesity, and metabolic disorders: Who is the chicken and who is the egg? Am J Clin Nutr 2017 105 3 4 10.3945/ajcn.116.14833828003208 Search in Google Scholar

[3] Ahmad R, Sorrell MF, Batra SK, Dhawan P, Singh AB. Gut permeability and mucosal inflammation: Bad, good or context dependent. Mucosal Immunol. 2017; 10: 307–317. AhmadR SorrellMF BatraSK DhawanP SinghAB Gut permeability and mucosal inflammation: Bad, good or context dependent Mucosal Immunol 2017 10 307 317 10.1038/mi.2016.128617134828120842 Search in Google Scholar

[4] Janczy A, Kochan Z, Małgorzewicz S. Endotoxemia and intestinal barrier disorders associated with overweight and obesity. Post Mikrobiol Adv Microbiol. 2019; 58: 427–432. JanczyA KochanZ MałgorzewiczS Endotoxemia and intestinal barrier disorders associated with overweight and obesity Post Mikrobiol Adv Microbiol 2019 58 427 432 10.21307/PM-2019.58.4.427 Search in Google Scholar

[5] Caricilli AM, Castoldi A, Câmara NO. Intestinal barrier: A gentlemen’s agreement between microbiota and immunity. World J Gastrointest Pathophysiol. 2014; 5: 18–32. CaricilliAM CastoldiA CâmaraNO Intestinal barrier: A gentlemen’s agreement between microbiota and immunity World J Gastrointest Pathophysiol 2014 5 18 32 10.4291/wjgp.v5.i1.18402451724891972 Search in Google Scholar

[6] Tokarz-Deptuła B, Śliwa-Dominiak J, Adamiak M, Bąk K, Deptuła W. Bakterie komensalne a odporność układu pokarmowego, oddechowego i moczowo-płciowego. Postepy Hig Med Dosw. 2016; 70, 599–609. Tokarz-DeptułaB Śliwa-DominiakJ AdamiakM BąkK DeptułaW Bakterie komensalne a odporność układu pokarmowego, oddechowego i moczowo-płciowego Postepy Hig Med Dosw 2016 70 599 609 10.5604/17322693.120495427333930 Search in Google Scholar

[7] Węgrzyn D, Adamek K, Łoniewska B. Structure of the intestinal barrier. Pomeranian J Life Sci. 2017; 63: 6–9. WęgrzynD AdamekK ŁoniewskaB Structure of the intestinal barrier Pomeranian J Life Sci 2017 63 6 9 Search in Google Scholar

[8] Lee SH. Intestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases. Intest Res. 2015; 9100: 11–18 LeeSH Intestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases Intest Res 2015 9100 11 18 10.5217/ir.2015.13.1.11431621625691839 Search in Google Scholar

[9] Casselbrant A, Elias E, Fändriks L, Wallenius V. Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2015; 11: 45–53. CasselbrantA EliasE FändriksL WalleniusV Expression of tight-junction proteins in human proximal small intestinal mucosa before and after Roux-en-Y gastric bypass surgery Surg Obes Relat Dis 2015 11 45 53 10.1016/j.soard.2014.05.00925264329 Search in Google Scholar

[10] Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013; 70: 631–659. SuzukiT Regulation of intestinal epithelial permeability by tight junctions Cell Mol Life Sci 2013 70 631 659 10.1007/s00018-012-1070-x22782113 Search in Google Scholar

[11] Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, Tsukita S. Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem. 2004; 279: 44785–44794. UmedaK MatsuiT NakayamaM FuruseK SasakiH FuruseM TsukitaS Establishment and characterization of cultured epithelial cells lacking expression of ZO-1 J Biol Chem 2004 279 44785 44794 10.1074/jbc.M40656320015292177 Search in Google Scholar

[12] Żak-Gołąb A, Kocełak P, Aptekorz M, Zientara M, Juszczyk L, Martirosian G, Chudek J, Olszanecka-Glinianowicz M. Gut microbiota, micro-inflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol. 2013; 2013: 674106. Żak-GołąbA KocełakP AptekorzM ZientaraM JuszczykL MartirosianG ChudekJ Olszanecka-GlinianowiczM Gut microbiota, micro-inflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects Int J Endocrinol 2013 2013 674106 10.1155/2013/674106373264423970898 Search in Google Scholar

[13] Kojima T, Murata M, Go M, Spray DC, Sawada N. Connexins induce and maintain tight junctions in epithelial cells. J Membrane Biol. 2007; 217: 13–19. KojimaT MurataM GoM SprayDC SawadaN Connexins induce and maintain tight junctions in epithelial cells J Membrane Biol 2007 217 13 19 10.1007/s00232-007-9021-417568974 Search in Google Scholar

[14] Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology, 2012; 142: 1100–1101.e2. PendyalaS WalkerJM HoltPR A high-fat diet is associated with endotoxemia that originates from the gut Gastroenterology 2012 142 1100 1101.e2 10.1053/j.gastro.2012.01.034397871822326433 Search in Google Scholar

[15] Raetz CRH, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002; 71: 635–700. RaetzCRH WhitfieldC Lipopolysaccharide endotoxins Annu Rev Biochem 2002 71 635 700 10.1146/annurev.biochem.71.110601.135414256985212045108 Search in Google Scholar

[16] Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans. Int Rev Immunol. 2016; 35: 189–218. GnauckA LentleRG KrugerMC The characteristics and function of bacterial lipopolysaccharides and their endotoxic potential in humans Int Rev Immunol 2016 35 189 218 10.3109/08830185.2015.108751826606737 Search in Google Scholar

[17] Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev. 2016; 40: 480–493. MaldonadoRF Sá-CorreiaI ValvanoMA Lipopolysaccharide modification in Gram-negative bacteria during chronic infection FEMS Microbiol Rev 2016 40 480 493 10.1093/femsre/fuw007493122727075488 Search in Google Scholar

[18] Wachowicz B, Saluk-Juszczak J. Aktywność prozapalna lipopolisacharydu. Post Bioch. 2015; 51, 280–287. WachowiczB Saluk-JuszczakJ Aktywność prozapalna lipopolisacharydu Post Bioch 2015 51 280 287 Search in Google Scholar

[19] Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients, 2020; 12: 1474. MagneF GottelandM GauthierL ZazuetaA PesoaS NavarreteP BalamuruganR The firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients 2020 12 1474 10.3390/nu12051474728521832438689 Search in Google Scholar

[20] Garrett WS. Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli). In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 2014; 2: 2773–2780. GarrettWS Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and Other Medically Important Anaerobic Gram-Negative Bacilli) In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases 2014 2 2773 2780 Search in Google Scholar

[21] Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009; 50: 90–97. GhoshalS WittaJ ZhongJ de VilliersW EckhardtE Chylomicrons promote intestinal absorption of lipopolysaccharides J Lipid Res 2009 50 90 97 10.1194/jlr.M800156-JLR20018815435 Search in Google Scholar

[22] Tuomi K, Logomarsino JV. Bacterial lipopolysaccharide, lipopolysaccharide-binding protein, and other inflammatory markers in obesity and after bariatric surgery. Metab Syndr Relat Disord. 2016; 14: 279–288. TuomiK LogomarsinoJV Bacterial lipopolysaccharide, lipopolysaccharide-binding protein, and other inflammatory markers in obesity and after bariatric surgery Metab Syndr Relat Disord 2016 14 279 288 10.1089/met.2015.017027228236 Search in Google Scholar

[23] Huang TT, Lai JB, Du YL, Xu Y, Ruan LM, Hu SH. Current understanding of gut microbiota in mood disorders: An update of human studies. Front. Genet., 2019; 10: 98. HuangTT LaiJB DuYL XuY RuanLM HuSH Current understanding of gut microbiota in mood disorders: An update of human studies Front. Genet. 2019 10 98 10.3389/fgene.2019.00098638972030838027 Search in Google Scholar

[24] Laugerette F, Vors C, Peretti N, Michalski MC. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie, 2011; 93: 39–45. LaugeretteF VorsC PerettiN MichalskiMC Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation Biochimie 2011 93 39 45 10.1016/j.biochi.2010.04.01620433893 Search in Google Scholar

[25] Donnenberg MS. Enterobacteriaceae. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 2014; 2: 2503–2517. DonnenbergMS Enterobacteriaceae In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases 2014 2 2503 2517 Search in Google Scholar

[26] Nighot M, Al-Sadi R, Guo S, Rawat M, Nighot P, Watterson MD, Ma TY. Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by Toll-like receptor 4/myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression. Am J Pathol. 2017; 187: 2698–2710. NighotM Al-SadiR GuoS RawatM NighotP WattersonMD MaTY Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by Toll-like receptor 4/myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression Am J Pathol 2017 187 2698 2710 10.1016/j.ajpath.2017.08.005571809629157665 Search in Google Scholar

[27] Guo S, Nighot M, Al-Sadi R, Alhmoud T, Nighot P, Ma TY. Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88. J Immunol. 2015; 195: 4999–5010. GuoS NighotM Al-SadiR AlhmoudT NighotP MaTY Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88 J Immunol 2015 195 4999 5010 10.4049/jimmunol.1402598463723726466961 Search in Google Scholar

[28] Cao S, Zhang Q, Wang C, Wu H, Jiao L, Hong Q, Hu C. LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets. Innate Immun. 2018; 24: 221–230. CaoS ZhangQ WangC WuH JiaoL HongQ HuC LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets Innate Immun 2018 24 221 230 10.1177/1753425918769372683092129642727 Search in Google Scholar

[29] Fan K, Lin L, Ai Q, Wan J, Dai J, Liu G, Tang L, Yang Y, Ge P, Jiang R, Zhang L. Lipopolysaccharide-induced dephosphorylation of AMPK-activated protein kinase potentiates inflammatory injury via repression of ULK1-dependent autophagy. Front Immunol. 2018; 9: 1464. FanK LinL AiQ WanJ DaiJ LiuG TangL YangY GeP JiangR ZhangL Lipopolysaccharide-induced dephosphorylation of AMPK-activated protein kinase potentiates inflammatory injury via repression of ULK1-dependent autophagy Front Immunol 2018 9 1464 10.3389/fimmu.2018.01464602664829988556 Search in Google Scholar

[30] Przewłócka K, Folwarski M, Kaźmierczak-Siedlecka K, SkoniecznaŻydeck K, Kaczor JJ. Gut-muscle axis exists and may affect skeletal muscle adaptation to training. Nutrients, 2020; 12: 1451. PrzewłóckaK FolwarskiM Kaźmierczak-SiedleckaK SkoniecznaŻydeckK KaczorJJ Gut-muscle axis exists and may affect skeletal muscle adaptation to training Nutrients 2020 12 1451 10.3390/nu12051451728519332443396 Search in Google Scholar

[31] Raulien N, Friedrich K, Strobel S, Rubner S, Baumann S, von Bergen M, Körner A, Krueger M, Rossol M, Wagner U. Fatty acid oxidation compensates for lipopolysaccharide-induced Warburg effect in glucose-deprived monocytes. Front. Immunol., 2017; 8: 609. RaulienN FriedrichK StrobelS RubnerS BaumannS von BergenM KörnerA KruegerM RossolM WagnerU Fatty acid oxidation compensates for lipopolysaccharide-induced Warburg effect in glucose-deprived monocytes Front. Immunol. 2017 8 609 10.3389/fimmu.2017.00609544703928611773 Search in Google Scholar

[32] Silwal P, Kim JK, Yuk JM, Jo EK. AMP-activated protein kinase and host defense against infection. Int J Mol Sci. 2018; 19: 3495. SilwalP KimJK YukJM JoEK AMP-activated protein kinase and host defense against infection Int J Mol Sci 2018 19 3495 10.3390/ijms19113495627499030404221 Search in Google Scholar

[33] Guevara-Cruz M, Godinez-Salas ET, Sanchez-Tapia M, Torres-Villalobos G, Pichardo-Ontiveros E, Guizar-Heredia R, Arteaga-Sanchez L, Gamba G, Mojica-Espinosa R, Schcolnik-Cabrera A, et al. Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects. BMJ Open Diabetes Res Care. 2020; 8: e000948. Guevara-CruzM Godinez-SalasET Sanchez-TapiaM Torres-VillalobosG Pichardo-OntiverosE Guizar-HerediaR Arteaga-SanchezL GambaG Mojica-EspinosaR Schcolnik-CabreraA Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects BMJ Open Diabetes Res Care 2020 8 e000948 10.1136/bmjdrc-2019-000948706408532152146 Search in Google Scholar

[34] Sun X, Zhu MJ. AMP-activated protein kinase: A therapeutic target in intestinal diseases. Open Biol. 2017; 7: 170104. SunX ZhuMJ AMP-activated protein kinase: A therapeutic target in intestinal diseases Open Biol 2017 7 170104 10.1098/rsob.170104557744828835570 Search in Google Scholar

[35] Zachorska-Markiewicz B, Kocełak P. Rola układu kannabinoidowego w regulacji poboru pokarmu. Endokrynol Otył Zab Przem Mat. 2005; 1: 12–17. Zachorska-MarkiewiczB KocełakP Rola układu kannabinoidowego w regulacji poboru pokarmu Endokrynol Otył Zab Przem Mat 2005 1 12 17 Search in Google Scholar

[36] Dipatrizio NV. Endocannabinoids in the gut. Cannabis Cannabinoid Res. 2016; 1: 67–77. DipatrizioNV Endocannabinoids in the gut Cannabis Cannabinoid Res 2016 1 67 77 10.1089/can.2016.0001494013327413788 Search in Google Scholar

[37] Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 2010; 6: 392. MuccioliGG NaslainD BäckhedF ReigstadCS LambertDM DelzenneNM CaniPD The endocannabinoid system links gut microbiota to adipogenesis Mol Syst Biol 2010 6 392 10.1038/msb.2010.46292552520664638 Search in Google Scholar

[38] Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007; 56, 1761–1772. CaniPD AmarJ IglesiasMA PoggiM KnaufC BastelicaD NeyrinckAM FavaF TuohyKM ChaboC Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 2007 56 1761 1772 10.2337/db06-149117456850 Search in Google Scholar

[39] Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M, et al.: A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol. 2013; 87, 357–367. XiaoS FeiN PangX ShenJ WangL ZhangB ZhangM ZhangX ZhangC LiM A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome FEMS Microbiol Ecol 2013 87 357 367 10.1111/1574-6941.12228425529124117923 Search in Google Scholar

[40] Cani PD, Possemiers S, Van De Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009; 58: 1091–1103. CaniPD PossemiersS Van De WieleT GuiotY EverardA RottierO GeurtsL NaslainD NeyrinckA LambertDM Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability Gut 2009 58 1091 1103 10.1136/gut.2008.165886270283119240062 Search in Google Scholar

[41] Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013; 110: 9066–9071. EverardA BelzerC GeurtsL OuwerkerkJP DruartC BindelsLB GuiotY DerrienM MuccioliGG DelzenneNM Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity Proc Natl Acad Sci USA 2013 110 9066 9071 10.1073/pnas.1219451110367039823671105 Search in Google Scholar

[42] Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat Med. 2019; 25: 1096–1103. DepommierC EverardA DruartC PlovierH Van HulM Vieira-SilvaS FalonyG RaesJ MaiterD DelzenneNM Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study Nat Med 2019 25 1096 1103 10.1038/s41591-019-0495-2669999031263284 Search in Google Scholar

[43] Ciobârcă D, Cătoi AF, Copăescu C, Miere D, Crișan G. Bariatric surgery in obesity: Effects on gut microbiota and micronutrient status. Nutrients. 2020; 12: 235. CiobârcăD CătoiAF CopăescuC MiereD CrișanG Bariatric surgery in obesity: Effects on gut microbiota and micronutrient status Nutrients 2020 12 235 10.3390/nu12010235701960231963247 Search in Google Scholar

[44] Guo Y, Liu CQ, Liu GP, Huang ZP, Zou DJ. Roux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats. J Diabetes. 2019; 11: 786–793. GuoY LiuCQ LiuGP HuangZP ZouDJ Roux-en-Y gastric bypass decreases endotoxemia and inflammatory stress in association with improvements in gut permeability in obese diabetic rats J Diabetes 2019 11 786 793 10.1111/1753-0407.1290630714321 Search in Google Scholar

[45] Morales-Marroquin E, Hanson B, Greathouse L, de la Cruz-Munoz N, Messiah SE. Comparison of methodological approaches to human gut microbiota changes in response to metabolic and bariatric surgery: A systematic review. Obes. Rev., 2020; 21: e13025. Morales-MarroquinE HansonB GreathouseL de la Cruz-MunozN MessiahSE Comparison of methodological approaches to human gut microbiota changes in response to metabolic and bariatric surgery: A systematic review Obes. Rev. 2020 21 e13025 10.1111/obr.1302532249534 Search in Google Scholar

[46] Aron-Wisnewsky J, Doré J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012; 9: 590–598. Aron-WisnewskyJ DoréJ ClementK The importance of the gut microbiota after bariatric surgery Nat Rev Gastroenterol Hepatol 2012 9 590 598 10.1038/nrgastro.2012.16122926153 Search in Google Scholar

[47] Wagner NRF, Zaparolli MR, Cruz MRR, Schieferdecker MEM, Campos ACL. Postoperative changes in intestinal microbiota and use of probiotics in Roux-En-Y gastric bypass and sleeve vertical gastrectomy: An integrative review. Arq Bras Cir Dig. 2018; 31: e1400. WagnerNRF ZaparolliMR CruzMRR SchieferdeckerMEM CamposACL Postoperative changes in intestinal microbiota and use of probiotics in Roux-En-Y gastric bypass and sleeve vertical gastrectomy: An integrative review Arq Bras Cir Dig. 2018 31 e1400 10.1590/0102-672020180001e1400628437330539975 Search in Google Scholar

[48] Duranti S, Ferrario C, van Sinderen D, Ventura M, Turroni F. Obesity and microbiota: An example of an intricate relationship. Genes Nutr. 2017; 12: 18. DurantiS FerrarioC van SinderenD VenturaM TurroniF Obesity and microbiota: An example of an intricate relationship Genes Nutr 2017 12 18 10.1186/s12263-017-0566-2547300028638490 Search in Google Scholar

[49] Wang W, Cheng Z, Wang Y, Dai Y, Zhang X, Hu S. Role of bile acids in bariatric surgery. Front Physiol. 2019; 10: 374. WangW ChengZ WangY DaiY ZhangX HuS Role of bile acids in bariatric surgery Front Physiol 2019 10 374 10.3389/fphys.2019.00374645439131001146 Search in Google Scholar

[50] Hankir MK, Langseder T, Bankoglu EE, Ghoreishi Y, Dischinger U, Kurlbaum M, Kroiss M, Otto C, le Roux CW, Arora T, et al. Simulating the post-gastric bypass intestinal microenvironment uncovers a barrier-stabilizing role for FXR. iScience, 2020; 23: 101777. HankirMK LangsederT BankogluEE GhoreishiY DischingerU KurlbaumM KroissM OttoC le RouxCW AroraT Simulating the post-gastric bypass intestinal microenvironment uncovers a barrier-stabilizing role for FXR iScience 2020 23 101777 10.1016/j.isci.2020.101777768955533294786 Search in Google Scholar

[51] Monte SV, Caruana JA, Ghanim H, Sia CL, Korzeniewski K, Schentag JJ, Dandona P. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery, 2012; 151: 587–593. MonteSV CaruanaJA GhanimH SiaCL KorzeniewskiK SchentagJJ DandonaP Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus Surgery 2012 151 587 593 10.1016/j.surg.2011.09.03822088821 Search in Google Scholar

[52] Yang PJ, Lee WJ, Tseng PH, Lee PH, Lin MT, Yang WS. Bariatric surgery decreased the serum level of an endotoxin-associated marker: Lipopolysaccharide-binding protein. Surg Obes Relat Dis. 2014; 10: 1182–1187. YangPJ LeeWJ TsengPH LeePH LinMT YangWS Bariatric surgery decreased the serum level of an endotoxin-associated marker: Lipopolysaccharide-binding protein Surg Obes Relat Dis 2014 10 1182 1187 10.1016/j.soard.2014.02.02224713521 Search in Google Scholar

[53] Mokhtari Z, Karbaschian Z, Pazouki A, Kabir A, Hedayati M, Mirmiran P. The effects of probiotic supplements on blood markers of endotoxin and lipid peroxidation in patients undergoing gastric bypass surgery; A randomized, double-blind, placebo-controlled, clinical trial with 13 months follow-up. Obes Surg. 2019; 29: 1248–1258. MokhtariZ KarbaschianZ PazoukiA KabirA HedayatiM MirmiranP The effects of probiotic supplements on blood markers of endotoxin and lipid peroxidation in patients undergoing gastric bypass surgery; A randomized, double-blind, placebo-controlled, clinical trial with 13 months follow-up Obes Surg 2019 29 1248 1258 10.1007/s11695-018-03667-630612325 Search in Google Scholar

[54] Clemente-Postigo M, Roca-Rodriguez MDM, Camargo A, Ocaña-Wilhelmi L, Cardona F, Tinahones FJ. Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery. Surg Obes Relat Dis. 2015; 11: 933–939. Clemente-PostigoM Roca-RodriguezMDM CamargoA Ocaña-WilhelmiL CardonaF TinahonesFJ Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery Surg Obes Relat Dis 2015 11 933 939 10.1016/j.soard.2014.11.03025737102 Search in Google Scholar

[55] Trøseid M, Nestvold TK, Rudi K, Thoresen H, Nielsen EW, Lappegård KT. Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: Evidence from bariatric surgery. Diabetes Care, 2013; 36: 3627–3632. TrøseidM NestvoldTK RudiK ThoresenH NielsenEW LappegårdKT Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: Evidence from bariatric surgery Diabetes Care 2013 36 3627 3632 10.2337/dc13-0451381687623835694 Search in Google Scholar

[56] Van Dielen FMH, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004; 89: 4062–4068. Van DielenFMH BuurmanWA HadfouneM NijhuisJ GreveJW Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery J Clin Endocrinol Metab 2004 89 4062 4068 10.1210/jc.2003-03212515292349 Search in Google Scholar

[57] Li Y, Guan W, Ma S, Lin S, Yang N, Liu R, Liang H, Zhou H. Lipopolysaccharide and inflammatory cytokines levels decreased after sleeve gastrectomy in Chinese adults with obesity. Endocr J. 2019; 66: 337–347. LiY GuanW MaS LinS YangN LiuR LiangH ZhouH Lipopolysaccharide and inflammatory cytokines levels decreased after sleeve gastrectomy in Chinese adults with obesity Endocr J 2019 66 337 347 10.1507/endocrj.EJ18-044630799316 Search in Google Scholar

[58] Blanchard C, Moreau F, Chevalier J, Ayer A, Garcon D, Arnaud L, Pais de Barros JP, Gautier T, Neunlist M, Cariou B, Le May C. Sleeve gastrectomy alters intestinal permeability in diet-induced obese mice. Obes Surg. 2017; 27: 2590–2598. BlanchardC MoreauF ChevalierJ AyerA GarconD ArnaudL Pais de BarrosJP GautierT NeunlistM CariouB Le MayC Sleeve gastrectomy alters intestinal permeability in diet-induced obese mice Obes Surg 2017 27 2590 2598 10.1007/s11695-017-2670-128429171 Search in Google Scholar